Principal Securities Inc. Buys 3,325 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Principal Securities Inc. raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 37.9% during the 4th quarter, Holdings Channel reports. The fund owned 12,106 shares of the exchange traded fund’s stock after purchasing an additional 3,325 shares during the period. Principal Securities Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,090,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of XBI. Healthcare of Ontario Pension Plan Trust Fund boosted its position in SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF during the 3rd quarter valued at $141,284,000. Assetmark Inc. boosted its position in shares of SPDR S&P Biotech ETF by 72,653.0% in the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after purchasing an additional 588,489 shares in the last quarter. Sivik Global Healthcare LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth $29,640,000. Finally, Mirae Asset Securities USA Inc. boosted its position in shares of SPDR S&P Biotech ETF by 50.0% in the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after purchasing an additional 300,000 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $92.53 on Thursday. The stock has a market capitalization of $7.05 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The business has a fifty day moving average price of $91.42 and a 200-day moving average price of $96.00.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.